thymoglobulin
Search documents
SAB Biotherapeutics (NasdaqCM:SABS) FY Conference Transcript
2025-11-12 16:00
SAB Biotherapeutics (NasdaqCM:SABS) FY Conference November 12, 2025 10:00 AM ET Speaker0Welcome to Guggenheim Healthcare Innovation Conference. My name is Yatin Suneja, one of the biotech analyst, here at the firm. It is my pleasure, to welcome our next presenting company, SAB Biotherapeutics. From the company, we have few executives here. We have Sam Wright, who's the chairman and chief executive officer, and then we also have Lucy To.She's the chief financial officer. So we will be having discussion with ...